| Literature DB >> 24081534 |
Shuhei Mayanagi1, Tetsuro Onitsuka, Masahiro Nakagawa, Hiroshi Sato, Yuko Kitagawa, Yasuhiro Tsubosa.
Abstract
BACKGROUND: Salvage surgery after definitive chemoradiotherapy for cervical esophageal cancer and hypopharyngeal cancer remains a challenge because of the high rate of complications. The purpose of this study was to evaluate the safety and efficacy of free jejunal transfer as salvage surgery for cervical esophageal cancer and hypopharyngeal cancer after definitive chemoradiotherapy.Entities:
Mesh:
Year: 2014 PMID: 24081534 PMCID: PMC3868873 DOI: 10.1007/s00268-013-2229-9
Source DB: PubMed Journal: World J Surg ISSN: 0364-2313 Impact factor: 3.352
Fig. 1Free jejunal transfer. Top The harvested free jejunal graft had two vascular pedicles; a second jejunal artery/vein (a) and a third jejunal artery/vein (b). Bottom The second jejunal artery was anastomosed to the right superficial cervical artery (a). The third jejunal artery was anastomosed to the left superficial cervical artery (b)
Patient characteristics
| Age (year), median (range) | 65 | (49–77) |
| Gender | ||
| Male | 17 | 89 % |
| Female | 2 | 11 % |
| Anatomical subsite | ||
| Cervical esophagus | 8 | 42 % |
| Hypopharynx | 11 | 58 % |
| Preoperative diagnosis | ||
| Cervical esophagus | ||
| Stage IIA | 1 | 5 % |
| Stage III | 6 | 32 % |
| Stage IVB | 1 | 5 % |
| Hypopharynx | ||
| Stage I | 1 | 5 % |
| Stage III | 2 | 11 % |
| Stage IVA | 8 | 42 % |
| Preoperative treatment | ||
| RT alone | 1 | 5% |
| CRT | ||
| 5-FU+cisplatin+RT | 7 | 37 % |
| 5-FU+carboplatin+RT | 2 | 11 % |
| 5-FU+nedaplatin+RT | 1 | 5 % |
| Cisplatin+RT | 7 | 37 % |
| Unspecified regimen + RT | 1 | 5 % |
| Dose of radiation (Gy), median (range) | 66 | (58–70) |
RT radiotherapy, CRT chemoradiotherapy, FU fluorouracil
Surgical outcomes
| Length of operation (min), median (range) | 514 | (329–739) |
| Intraoperative blood loss (ml), median (range) | 439 | (80–1,430) |
| Duration from CRT to surgery (days), median (range) | 218 | (88–3,043) |
| Postoperative hospital (days), median (range) | 18 | (14–38) |
| No. of dissected lymph nodes, median (range) | 7 | (0–38) |
| Recipient vessels for free jejunal transfer | ||
| One artery and one vein | ||
| STA | 7 | 37 % |
| SCA | 2 | 11 % |
| LA | 2 | 11 % |
| TCA | 1 | 5 % |
| One artery and two veins | ||
| TCA | 1 | 5 % |
| Two arteries and two veins | ||
| LA + SCA | 2 | 11 % |
| LA + STA | 1 | 5 % |
| STA + SCA | 1 | 5 % |
| STA + TCA | 1 | 5 % |
| Bilateral SCA | 1 | 5 % |
| Complications | ||
| Partial necrosis of tracheal margin | 6 | 32 % |
| Anastomotic stenosis | 3 | 16 % |
| Fistula | 1 | 5 % |
| Abdominal incisional hernia | 1 | 5 % |
| Wound infection | 1 | 5 % |
RT radiotherapy, CRT chemoradiotherapy, FU fluorouracil, STA superior thyroid artery, SCA superficial cervical artery, LA lingual artery, TCA transverse cervical artery
Fig. 2Disease-specific survival curve following salvage surgery
Comparison of reported studies for complications
| Author | Patients | Reconstruction type | Previous radiation (%) | Fistula (%) | Stenosis (%) | Flap loss (%) | Mortality rate (%) |
|---|---|---|---|---|---|---|---|
| Our study | 19 | FJT | 100 | 5 | 16 | 0 | 0 |
| Miyamoto et al. [ | 86 | FJT | 100 | 12 | NA | 4 | 2 |
| Kadota et al. [ | 40 | FJT | 100 | 13 | 0 | 5 | 0 |
| Yu et al. [ | 114 | ATF | 67 | 9 | 6 | 2 | 2 |
| Murray et al. [ | 14 | ATF | 21 | 0 | 14 | 0 | 0 |
| Genden et al. [ | 12 | ATF | 83 | 9 | 9 | 8 | 0 |
| Azizzadeh et al. [ | 20 | RFFF | 85 | 20 | 20 | 0 | 0 |
| Scharpf et al. [ | 28 | RFFF | 72 | 28 | 36 | 0 | 0 |
| Genden et al. [ | 11 | RFFF | 73 | 8 | 27 | 0 | 0 |
| Zbar et al. [ | 24 | PMMF | 100 | NA | NA | 13 | 0 |
| Dubsky et al. [ | 8 | FJT and PMMF | 71 | 0 | 13 | 0 | 0 |
FJT free jejunal transfer, PMMF pectoralis major myofascial flap, RFFF radial forearm free flap, ATF anterolateral thigh flap, NA data not quoted or not possible to interpret accurately